|
PHARMACY-PHARMACODYNAMICS Course Descriptions |
HSC 245 |
392-3408 |
|---|
UNDERGRADUATE ADVISER(S): M. MCKENZIE, M. MELDRUM
|
GRADUATE ADVISER: M. KATOVICH
|
| DEPT-CRSE |
CF |
CC | GE |
REQ | SECT |
CRED | -DAY(S)- |
PERIOD | BLDG |
ROOM | EXAM |
COURSE-TITLE-OF-SECTION |
INSTRUCTOR |
| MCB 5252 | | |
| X | 2275X |
04 | TBA | |
| | NFE |
MICROBIO/IMMUN THERAP | STAFF |
|
PHA 4902 |
| |
| X | 3861X |
VAR | TBA | |
| | NFE |
PROB PHARMACODYNAMICS | STAFF |
| PHA 5515 | | |
| X | 7258X |
01 | TBA | |
| | FE |
PRINC OF PHARMACOLOGY | PERIS |
| PHA 5517 | | |
| X | 7259X |
04 | TBA | |
| | FE |
PHARMACOL BAS THER 2 | MELDRUM |
|
PHA 5531 |
| |
| X | 8255X |
02 | TBA | |
| | NFE |
NEUROTOXICOLOGY | DAWSON JR |
| PHA 5561C | | |
| Z | 7260Z |
05 | TBA | |
| | FE |
PHYSIOL BAS DISEASE 2 | GAUSE |
| PHA 5561C | | |
| Z | 7261Z |
05 | TBA | |
| | FE |
PHYSIOL BAS DISEASE 2 | GAUSE |
| PHA 5561C | | |
| Z | 7262Z |
05 | TBA | |
| | FE |
PHYSIOL BAS DISEASE 2 | GAUSE |
| PHA 5561C | | |
| Z | 7263Z |
05 | TBA | |
| | FE |
PHYSIOL BAS DISEASE 2 | GAUSE |
| PHA 5561C | | |
| Z | 7264Z |
05 | TBA | |
| | FE |
PHYSIOL BAS DISEASE 2 | GAUSE |
| PHA 5561C | | |
| Z | 7265Z |
05 | TBA | |
| | FE |
PHYSIOL BAS DISEASE 2 | GAUSE |
| PHA 5561C | | |
| Z | 7266Z |
05 | TBA | |
| | FE |
PHYSIOL BAS DISEASE 2 | GAUSE |
| PHA 5902 | | |
| X | 3868X |
VAR | TBA | |
| | NFE |
RESEARCH PHARMACODYNA | STAFF |
|
PHA 6540 |
| |
| X | 7271X |
03 | TBA | |
| | FE |
NEUROCHEM FOUNDA | PERIS |
|
PHA 6938 |
| |
| X | 7272X |
01 | TBA | |
| | FE |
RESEARCH SEMINAR | DAWSON JR |
|
PHA 6971 |
| |
| X | 3270X |
VAR | TBA | |
| | NFE |
MASTERS RESEARCH | DAWSON JR |
|
PHA 7939 |
| |
| X | 7273X |
01 | TBA | |
| | FE |
JOURN COLLOQ PHARMACO | PERIS |
|
PHA 7979 |
| |
| X | 7274X |
VAR | TBA | |
| | FE |
ADVANCED RESEARCH | KELLER WOOD |
|
PHA 7980 |
| |
| X | 7275X |
VAR | TBA | |
| | FE |
DOCTORAL RESEARCH | MELDRUM |